Indische Firmen wie Mahamaya Lifesciences und Pine Labs starten Ende 2025 IPOs zur Expansion. Indian firms like Mahamaya Lifesciences and Pine Labs to launch IPOs in late 2025 for expansion.

Mehrere indische Unternehmen, darunter Mahamaya Lifesciences, Pine Labs, Curis Lifesciences, Seshaasai Technologies und Bliss GVS Pharma, werden Ende 2025 IPOs auf den Markt bringen, wobei Details zu Ausgabeterminen, Preisen, Losgrößen und Abonnementstatus von Investoren genau überwacht werden. Multiple Indian companies, including Mahamaya Lifesciences, Pine Labs, Curis Lifesciences, Seshaasai Technologies, and Bliss GVS Pharma, are set to launch IPOs in late 2025, with details on issue dates, pricing, lot sizes, and subscription status being closely monitored by investors.